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Introduction 
 
The diagnosis of curable, secondary causes of hypertension is a satisfying but challenging 
aspect, for both patient and doctor, of the clinical management of hypertension. They are 
probably under-recognized, and the enthusiasm to look for causes is blunted by low pickup 
rates in unselected patients. Young age encourages a search more because the alternative is 
many decades of drug treatment than because of any good evidence that prevalence of 
secondary hypertension varies with age.1 Plasma renin is still not a routine measurement 
even in the younger patient. And while there is increasing evidence that a low plasma renin is 
valuable in the detection of primary aldosteronism,2 a high plasma renin does not usually 
trigger investigations for renal artery stenosis. The cases we present here are not part of a 
formal prospective series. But they illustrate how valuable was the finding of an extremely 
high plasma renin, leading to re-evaluation of MR- and CT-angiograms in the light of a high 
rather than low prior probability. Our report is stimulated by the coincidence of five such 
patients being diagnosed within an 18-month period, and a parallel prospective study of 
plasma renin concentration’s prediction of treatment response, which enabled us to define 
the threshold for an ‘extremely high plasma renin’.3 We will discuss the significance of the log-
distribution of renin, of factors such as drug treatment influencing interpretation, and of 
reviewing reportedly normal radiology.  
 
Plasma renin concentration was measured by the Diasorin Liaison automated immunoassay 
analyser.4 Intra-assay coefficients of variation (CV's) were 3.7%, 2.8%, 2.0% and 1.2% at 
concentrations of 15.1, 33.8, 82.2 and 258.0 mU/l respectively. Inter-assay CV's were 5.8% 
and 4.9% at concentrations of 25.6 and 101.3 mU/l respectively. The lower limit of 
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quantitation of the assay, as specified by the manufacturer, was 2.0 mU/l.  Plasma renin 
activity is reported for one patient, in whom this was measured at the referring hospital. 
  
Patient 1  
A 24-year-old Caucasian woman was referred in 2013 with a 2-year history of hypertension.5 
Despite treatment with ramipril 5 mg daily and lercanidipine 20 mg daily, home systolic blood 
pressure readings often exceeded 140 mmHg. Cardiovascular examination was normal with 
no abdominal bruits; ECG and echocardiogram were also normal, as were serum electrolytes 
and eGFR. An MR angiogram at the referring hospital noted normal renal arteries. However, 
her plasma renin was at least 50-fold above normal at 4220 mU/L (normal values 5·4-60) and 
aldosterone was 1130 pmol/L (normal values 100-450). The increase in renin was many-fold 
more than could be easily ascribed to treatment with an ACE inhibitor, and this should have 
reduced levels of aldosterone. On review of the MR-angiogram at the Multi-Disciplinary Team 
(MDT) meeting, no definite abnormality of the arteries was observed, but the right kidney 
looked hypo-perfused (Figure 1a). Its length was 9.9 cms, and the left kidney was 11.0 cms. A 
formal renal angiogram was performed. This showed a tight stenosis in the mid segment of 
the right renal artery (Figure 1b), which was successfully treated by angioplasty (Figure 1c). 
One month later, average blood pressure was 122/75 mmHg on ramipril 5 mg daily, which 
was then discontinued without rise in blood pressure. The plasma renin and aldosterone 
levels fell post-angioplasty to 97 mU/L and 517 pmol/L, respectively. 
 
Patient 2  
A 26-year-old Caucasian woman was referred in 2014 with a 2-year history of hypertension. 
She had presented with a blood pressure of 220/100 mmHg during a follow-up visit for the 
prescription of a combined oral contraceptive pill. Serum electrolytes and eGFR were normal. 
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Her blood pressure remained elevated despite withdrawal of the contraceptive pill and she 
was treated with doxazosin 8 mg, ramipril 5 mg, bisoprolol 5 mg, and amlodipine 10 mg, each 
daily. A CT angiogram had shown normal renal arteries, and because of the number of 
medications required in a young patient, she was referred for specialist review. This 
confirmed the report on the CT angiogram. Plasma renin concentration, on two visits, was 
increased at 385 mU/L and 764 mU/L, while plasma aldosterone was normal at 296 pmol/L. 
Renal vein renin sampling was performed, showing values of 500-600 mU/L in both veins, 
with no clear gradient between these. Because the plasma renin concentrations were 
exceptionally high for a patient on beta-blockade, a renin-secreting tumour was considered 
and a triple phase CT angiogram requested. This showed that the left kidney, at 9.0 cms, had 
diminished in size, and the right kidney increased, to 11.9 cms, since the previous CT 
angiogram 10 months earlier; on the arterial phase a tight stenosis was observed in the mid-
portion of the left renal artery (Figure 2a). A left renal artery angioplasty was arranged 
(Figures 2b and 2c). Two months later, blood pressure was 128/67 mmHg on ramipril 10 mg, 
and this was discontinued. One year later, blood pressure was 146/96 mmHg on no treatment, 
and candesartan 4 mg daily was commenced. Plasma renin and aldosterone concentrations 
while untreated were 17 mU/L and 94 pmol/L. 
 
Patient 3 
A 23-year-old lady was referred in 2015 with continuous, severe headaches and severe, 
refractory hypertension. She had been well until approximately one year earlier, when she 
was hospitalized because of headache and blood pressure above 210/130 mmHg. She was an 
ex-smoker with no family history of hypertension, and she had proteinuria but normal renal 
function and negative screening for renal vasculitis. On the echocardiogram, the left ventricle 
was mildly dilated with moderate systolic impairment. On two occasions, the serum 
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potassium levels were slightly reduced (3·4 and 3·2 mEq/L; normal values 3·5 to 5·5), but 
other electrolytes and eGFR were normal. While on treatment with ramipril 2·5 mg and 
amlodipine 10 mg daily, her plasma renin activity and plasma aldosterone were raised at 21·2 
nmol/L/hour (normal values: 0·5-3·5), and 1840 pmol/L. She was additionally prescribed 
doxazosin 12 mg, indapamide 2·5 mg, bisoprolol 5 mg without effect on her blood pressure. 
Repeat plasma renin activity and aldosterone were 5·9 nmol/L/hour and 2010 pmol/L, 
respectively. A CT-scan reportedly showed no evidence of renal artery stenosis or any adrenal 
lesion. Cardiac and aortic MRI excluded coarctation. Following referral the plasma renin 
concentration was measured at 144 mu/L. Review of the original, axial CT images showed no 
abnormality of single renal arteries on each side. However, the several-fold elevation of 
plasma renin despite beta-blockade, and our experience of the previous three patients, 
prompted further review with coronal reconstruction of the images. On these, a second renal 
artery was detected on the right, with a tight stenosis about 2 cm from the origin, suggestive 
of fibromuscular dysplasia (Figure 3a). A renal artery angioplasty was performed (Figure 
3b-c). A month later, her headaches had disappeared, blood pressure had fallen to 127/85 
mmHg, and plasma renin to 17 mU/L; aldosterone was 510 pmol/L. At 3 months, blood 
pressure was 137/88 mmHg on no treatment. 
 
Patient 4 
A 56-year-old Caucasian woman was referred in 2014 with refractory hypertension.5 She had 
been diagnosed with hypertension approximately 30 years earlier and at the time of referral 
was on treatment with bisoprolol 5 mg, perindopril 8 mg, lercanidipine 20 mg, and 
spironolactone 25 mg, each daily. She complained of headaches and lethargy, and her blood 
pressure was 152/96 mmHg. Serum electrolytes and creatinine were normal, but TSH levels 
was slightly elevated at 5·6 mU/L (normal values: 0·35-5·5), together with marked elevation 
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of thyroid antibodies (anti-thyroid peroxidase 2147 iu/mL; normal values < 60), leading to 
the diagnosis of Hashimoto's thyroiditis. Plasma renin concentration was markedly elevated 
at 1230 mU/L. The CT scan at the referring hospital reported a large uncomplicated cyst on 
the right kidney. No abnormality was seen in the renal arteries, but the requested 
examination was not an angiogram. MDT review prompted by the elevated renin noted 
calcification in the aorta (Figure 4a). A CT angiogram was performed which this tim  showed 
typical appearances of bilateral renal fibromuscular dysplasia (Figure 4b). There was only a 
small fall in blood pressure and plasma renin concentration following initiation of treatment 
with levothyroxine 50 mcg,6 and so she proceeded to technically successful angioplasty of 
both renal arteries. Five months later, after discontinuation of spironolactone and 
lercanidipine, blood pressure was 146/95 mmHg; the plasma renin fell to 130 mU/L, and 
aldosterone to < 70 pmol/L.  
 
Patient 5 
A 59-year-old man was referred in 2013 with a blood pressure of 191/101 mmHg despite 
prescription of ramipril, bisoprolol, amlodipine, indapamide, spironolactone, doxazosin and 
methyldopa. Serum electrolytes and eGFR were normal, as were plasma renin concentration, 
41 mU/L, and plasma aldosterone, 198 pmol/L. The recently introduced Hypertensive 
Compliance Screen showed that none of his seven drugs were detectable in a spot urine 
sample.7, 8  His treatment was changed to a single tablet containing olmesartan, amlodipine 
and hydrochlorothiazide, on which his blood pressure fell to 125/72 mmHg, and he was 
discharged. A year later he was re-referred with blood pressure 175/110 mmHg. His 
medication was detectable, and plasma renin had risen to 1068 mU/L. Nebivolol was added, 
on which plasma renin fell to 102 mU/L, with little improvement in blood pressure. Review of 
the CT angiogram performed at the referring hospital in 2013 found no abnormality, and a 
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repeat was requested in view of the refractory hypertension and rise in plasma renin. This 
demonstrated a tight ostial stenosis on the left (Figure 5a). In view of uncontrolled 
hypertension despite compliance with therapy, and frequent episodes of angina despite 
coronary stenting, he proceeded to renal artery stenting (Figure 5b-c). Pre-procedure, he was 
admitted with angina and a blood pressure of 246/132 mmHg. Within 24 hours he was 
asymptomatic and blood pressure was 122/78 mmHg. Plasma renin at 24 hours was 13 mU/L. 
His blood pressure continued to fall, to 80/53 mmHg, at which point all treatment was 
stopped. Blood pressure rose to 164/87 mmHg, and olmesartan/amlodipine combination was 
restarted. Plasma renin off treatment was 7 mU/L. 
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Discussion 
 
Renovascular hypertension due to atherosclerosis or fibromuscular dysplasia is present in 1-
4% of hypertensive patients, and is probably the most common correctable cause of 
secondary hypertension after aldosterone-producing adenomas of the adrenal.1, 9, 10 Because 
these two conditions should, in theory, manifest plasma renin levels at opposite extremes of 
its distribution, this nowadays simple test might be considered a valuable addition to the 
routine investigation of patients with hypertension. However, there has been little evidence to 
support its use in diagnosis of renal artery stenosis, and plasma renin can be reduced when 
bilateral disease results in sodium retention.10, 11 In addition, an initially high plasma renin 
might be expected to fall towards normal as the development of systemic hypertension 
returns the post-stenosis pressure from low to ‘normal’.  Indeed, plasma renin levels are 
normal in approximately 50% of patients with renovascular hypertension while, conversely, 
increased levels may be found in up to 10% of patients with essential hypertension.12 
Although a tissue diagnosis is rarely made, the renal artery stenosis of younger patients is 
most likely due to fibromuscular dysplasia, as  in patients 1-4, rather than the atherosclerosis 
of older patients, and studies of captopril renography suggest renin-dependence in such 
patients.13  
 
Across all ages, FMD accounts for a minor proportion of all patients with renovascular disease, 
but intervention is more likely to achieve sustained cure both of the renal artery stenosis and 
the resulting hypertension.10, 14 Its management should not be influenced by the neutral 
outcomes in the large trials of revascularization, ASTRAL and CORAL, which generally 
excluded patients with FMD.15, 16 Moreover, the primary outcome of these trials was renal 
function, and the eligible patients were those in whom clinicians were unsure of management. 
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One trial required good blood pressure control at entry.17 The trials do not exclude continued 
search for patients with atherosclerotic renovascular disease in whom percutaneous 
revascularization may substantially improve blood pressure control. However, the outcome of 
intervention in both FMD and atherosclerotic renal artery disease may depend on how early 
the diagnosis is made, with the 30-year delay in patient 4 probably leading to some 
irreversibility of her hypertension. Initiation of medical treatment is also not hazard-free. The 
risk for renal function of treatment with ACE inhibitors or angiotensin receptor blockers in 
atherosclerotic renal artery stenosis is well recognised, and ascribed to their greater effect on 
efferent than afferent arteriolar tone.18 Their risks in FMD are less s udied, but we wondered 
whether initiation of treatment in patient 2 may have contributed to the tight stenosis and 
reduction in kidney size over a short period of time. The deterioration of patient 5 was less 
surprising, but still an illustration why not to rely on a recently normal angiogram if blood 
pressure and plasma renin concentration have risen substantially in the interval. 
 
While systematic screening for renovascular hypertension is not recommended, several 
clinical indications should alert the clinician to look for lesions in the renal artery. Young age, 
severe or refractory hypertension, diffuse atherosclerosis, incidental finding of asymmetric 
size of the kidneys, are just some of the conditions that should make the clinician suspicious 
for renovascular hypertension.10, 19 Such conditions were variously present in the five cases 
reported here and led the diagnostic clinician to perform early imaging procedures to assess 
the morphology of the renal arteries. Strikingly, these investigations were reported as normal, 
even in some instances on review after referral. In each case, the decision to either question 
or repeat the initial investigation was the greatly increased prior probability (of an 
abnormality being present) consequent on measurement of a very high plasma renin. The 
value of non-invasive (CT or MR) angiography in detection of renal artery stenosis, especially 
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the more distal lesions of FMD, was challenged in the RADISH study, but this in turn has been 
questioned.20, 21 It may be that in some centres, the initial failures of diagnosis in our patients 
would not have occurred, but the five patients came from five different secondary centres, and 
even review in a tertiary centre did not always detect an abnormality. 
 
The distribution of plasma renin is unusually broad, compared to most hormones, spanning 
four logarithmic units.3 There are many stimuli to renin secretion, and appropriate increases 
in plasma renin occur following salt-depletion, sympathetic activation, or interruption of the 
negative feedback by angiotensin II.22 While each of diuretics, calcium-blockers or alpha-
blockers, and ACE inhibitors or ARBs, may cause 50-100% elevation of plasma renin through, 
respectively, one of these mechanisms, this rarely results in a log-unit (10-fold) increase in 
plasma renin, even when the drugs are combined. In the PATHWAY-2 study, comparing 
mineralocorticoid with α- and β-adrenergic blockade in 285 patients already treated with 
each of diuretics, calcium-blockers and ACE inhibitors or ARBs, only 3% of patients had a 
plasma renin >660 mU/L, and only in these 3% of patients was renin-suppression (by β-
blockade) as likely to reduce blood pressure as the spironolactone.3 This prospective 
evaluation of renin concentration as a predictor of drug response quantifies the frequency of 
elevated plasma renin concentrations in multiply-treated patients, and offers some evidence 
that hypertension at the most extreme values of plasma renin may have a different 
pathogenesis from hypertension in other patients. At the least, the plasma renin 
concentrations in our five patients, of 1130, 764 (despite β-blockade), 144 (despite β-
blockade), 1230, and 1068 (102 on β-blockade) mU/L, seem unlikely to be due solely to the 
pharmacological actions of their treatment. Rather, we considered them to be probable 
evidence of the fourth stimulus to renin production – a low pressure within the afferent renal 
arterioles at the site of renin secretion. In such patients an elevated renin is more likely to be 
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the cause of hypertension rather than consequence of treatment. The potential for additive, 
logarithmic increases in plasma renin in response to multiple stimuli was not fully 
appreciated when renin was measured via its enzyme activity – since at high levels the assay 
runs out of renin substrate in the patient’s plasma.23 The patients illustrate how plasma renin 
can be interpreted despite concurrent antihypertensive treatment, but also the importance of 
recognizing the substantial impact of beta-blockade on expected levels. This class lowers 
blood pressure by blocking the sympathetic activation of renin, and its impact is illustrated by 
the 10-fold fall in case 5, following introduction of nebivolol.  
 
The final patient illustrates a possible new clue to the presence of a secondary cause. The 
Leicester urine compliance test has led to recognition that a substantially elevated blood 
pressure despite prescription of multiple drugs is often, even usually, due to complete non-
compliance. However, if blood pressure is unresponsive to all of the major drug classes, and 
compliance is confirmed, then expectations of a secondary cause become high.  
 
It is important to emphasize that this is a retrospective report of five individual cases, too 
numerous, we suggest, for the very high plasma renin concentration to have been a false 
pointer to diagnosis, but too few for us to comment on the overall sensitivity and specificity of 
plasma renin as a diagnostic test. We are not suggesting that all patients with extremely high 
plasma renin concentrations have an anatomical cause. Addition of high-dose diuretic to an 
ACE inhibitor or angiotensin receptor blocker was associated, in a prospective study, with 
rises to similar concentrations of plasma renin in about 2% of patients, but we do not know 
how often underlying renal ischemia contributes to such reactive rises.24 We have also not 
examined reasons why initial CT angiograms may have been misleading, but suggest that 
timing of films after injection of contrast may be critical.  
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In conclusion, we have presented five patients with severe hypertension due to renal artery 
stenosis, in whom the diagnosis was not appreciated on the initial CT or MR angiogram. 
Recognition of a plasma renin that is many-fold higher than the normal range, after 
accounting for background drug treatment, led to further evaluation and investigation. These 
cases may stimulate systematic prospective evaluation, and meanwhile encourag  greater 
measurement of plasma renin in young patients with hypertension, and patients with 
uncontrollable hypertension despite treatment with multiple drugs. 
 
Contributors 
MJB conceived the analysis, and designed the report. MP and MJB wrote the paper. BK 
undertook renovascular imaging, angioplasty and stenting, and advised on image 
presentation for the paper. KPT undertook renin estimations for the five patients, and all 
other patients contributing to recognition of the renin distribution, and advised on 
interpretation. All authors approved the final version of the paper. 
 
Disclosures 
NONE (all authors). 
Funding Sources 
MJB is a National Institute of Health Research Senior Investigator (award NF-SI-0512-10052) 
Acknowledgements 
To all five patients, and their referring doctors, and nurses involved in their care. 
 
  
Fo
r H
yp
ert
en
sio
n P
ee
r R
ev
iew
. D
o n
ot 
dis
trib
ute
.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
De
str
oy
 af
ter
 us
e.
 13
References 
 
1. Brown MJ, Mir FA. Secondary Hypertension. In: D. A. Warrell and T. M. Cox, eds. Oxford 
Textbook of Medicine Oxford: O.U.P.; 2011; DOI: 
10.1093/med/9780199204854.003.161703_update_002. 
2. Brown MJ. Primary Aldosteronism: the spectre of cure. Clin Endocrinol (Oxf). 
2015;82:785-8. 
3. Williams B, MacDonald TM, Morant S, Webb DJ, Sever P, McInnes G, Ford I, Cruickshank 
JK, Caulfield MJ, Salsbury J, Mackenzie I, Padmanabhan S, Brown MJ, for British Hypertension 
Society's Prevention and Treatment of Hypertension with Algorithm-based Therapy Studies 
Group. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal 
treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, 
crossover trial. Lancet. 2015;386:2059-2068. 
4. Dorrian CA, Toole BJ, Alvarez-Madrazo S, Kelly A, Connell JM, Wallace AM. A screening 
procedure for primary aldosteronism based on the Diasorin Liaison automated 
chemiluminescent immunoassay for direct renin. Ann Clin Biochem. 2010;47:195-199. 
5. Moser M, Setaro JF. Clinical practice. Resistant or difficult-to-control hypertension. N 
Engl J Med. 2006;355:385-392. 
6. Brown MJ, Salsbury J. Subacute hypertension caused by hypothyroid-induced 
endothelial dysfunction unmasking presumed fibromuscular dysplasia of the renal artery. J 
Hum Hypert. 2014;28. 
7. Tomaszewski M, White C, Patel P, Masca N, Damani R, Hepworth J, Samani NJ, Gupta P, 
Madira W, Stanley A, Williams B. High rates of non-adherence to antihypertensive treatment 
revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-
MS/MS) urine analysis. Heart. 2014;100:855-861. 
Fo
r H
yp
ert
en
sio
n P
ee
r R
ev
iew
. D
o n
ot 
dis
trib
ute
.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
De
str
oy
 af
ter
 us
e.
 14
8. Brown MJ. Resistant hypertension: resistance to treatment or resistance to taking 
treatment? Heart. 2014;100:821-822. 
9. Viera AJ, Neutze DM. Diagnosis of secondary hypertension: an age-based approach. 
American family physician. 2010;82:1471-1478. 
10. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. 2001;344:431-442. 
11. Goldblatt PJ. The Goldblatt experiment: a conceptual paradigm. In: J. H. Laragh and B. M. 
Brenner, ed. Hypertension: Pathophysiology, Diagnosis and Management New York: Raven; 
1995(p. 23-25). 
12. Derkx FH, Schalekamp MA. Renal artery stenosis and hypertension. Lancet. 
1994;344:237-239. 
13. Pickering TG. Diagnosis and evaluation of renovascular hypertension. Indications for 
therapy. Circulation. 1991;83:I147-I154. 
14. Trinquart L, Mounier-Vehier C, Sapoval M, Gagnon N, Plouin PF. Efficacy of 
revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic 
review and meta-analysis. Hypertension. 2010;56:525-532. 
15. Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, Cohen DJ, 
Matsumoto AH, Steffes M, Jaff MR, Prince MR, Lewis EF, Tuttle KR, Shapiro JI, Rundback JH, 
Massaro JM, D'Agostino RB, Sr., Dworkin LD. Stenting and medical therapy for atherosclerotic 
renal-artery stenosis. N Engl J Med. 2014;370:13-22. 
16. Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, Baigent C, Carr S, Chalmers N, Eadington 
D, Hamilton G, Lipkin G, Nicholson A, Scoble J. Revascularization versus medical therapy for 
renal-artery stenosis. N Engl J Med. 2009;361:1953-1962. 
17. Bax L, Woittiez AJ, Kouwenberg HJ, Mali WP, Buskens E, Beek FJ, Braam B, Huysmans 
FT, Schultze Kool LJ, Rutten MJ, Doorenbos CJ, Aarts JC, Rabelink TJ, Plouin PF, Raynaud A, van 
Montfrans GA, Reekers JA, van den Meiracker AH, Pattynama PM, van de Ven PJ, 
Fo
r H
yp
ert
en
sio
n P
ee
r R
ev
iew
. D
o n
ot 
dis
trib
ute
.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
De
str
oy
 af
ter
 us
e.
 15
Vroegindeweij D, Kroon AA, de Haan MW, Postma CT, Beutler JJ. Stent placement in patients 
with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. 
Ann Intern Med. 2009;150:840-8, W150-W151. 
18. Palmer BF. Renal Dysfunction Complicating the Treatment of Hypertension. New 
England Journal of Medicine. 2002;347:1256-1261. 
19. Gardner D, Shoback D. Greenspan's Basic and Clinical Endocrinology. 9th Edition (Lange 
Clinical Medicine). McGraw Hill. 2011 
20. Vasbinder GB, Nelemans PJ, Kessels AG, Kroon AA, Maki JH, Leiner T, Beek FJ, Korst MB, 
Flobbe K, de Haan MW, van Zwam WH, Postma CT, Hunink MG, de Leeuw PW, van 
Engelshoven JM, for Renal Artery Diagnostic Imaging Study in Hypertension Study Group. 
Accuracy of computed tomographic angiography and magnetic resonance angiography for 
diagnosing renal artery stenosis. Ann Intern Med. 2004;141:674-682. 
21. Glockner JF, Vrtiska TJ. Renal MR and CT angiography: current concepts. Abdominal 
imaging. 2007;32:407-420. 
22. Brown MJ. Renin: friend or foe? Hea t. 2007;93:1026-1033. 
23. Morganti A; European study group for the validation of DiaSorin LIAISON Direct Renin 
Assay. A comparative study on inter and intralaboratory reproducibility of renin 
measurement with a conventional enzymatic method and a new chemiluminescent assay of 
immunoreactive renin. J Hypertens. 2010;28:1307-1312. 
24. Brown MJ, Williams B, Morant SV, Webb DJ, Caulfield MJ, Cruickshank JK, Ford I, 
McInnes G, Sever P, Salsbury J, Mackenzie IS, Padmanabhan S, MacDonald TM, for British 
Hypertension Society's Prevention and Treatment of Hypertension with Algorithm-based 
Therapy Studies Group. Effect of amiloride, or amiloride plus hydrochlorothiazide, versus 
hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, 
double-blind randomised phase 4 trial. The lancet Diabetes & endocrinology. 2016;4:136-147.
Fo
r H
yp
ert
en
sio
n P
ee
r R
ev
iew
. D
o n
ot 
dis
trib
ute
.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
De
str
oy
 af
ter
 us
e.
 16
Legend to the figures 
 
Figure 1. Axial MRI-angiogram (Panel A) showing reduced perfusion of the right kidney 
(darker) when compared to the left kidney (brighter). A tight stenosis of the mid segment of 
the right renal artery (Panel B) was successfully treated by angioplasty (Panel C).  
 
Figure 2. A 3D reconstruction of the arterial phase of a CT-angiogram (Panel A) showing 
reduced size of the left kidney and a tight stenosis of the mid-portion of the left renal artery 
(arrow). Pre- and post-angioplasty left renal artery angiograms (Panel B and C, respectively). 
 
Figure 3. A 3D reconstruction of a CT-angiogram (Panel A) showing the presence of a second 
renal artery on the right, with a tight stenosis of the principal right renal artery (arrow). Pre- 
and post-angioplasty right renal artery angiograms (Panel B and C, respectively). 
 
Figure 4. Axial CT-scan of the abdomen (Panel A) showing liver cysts and calcification of the 
aorta (arrow). 3-D reconstructions of the arterial phase of a repeated CT-scan of the abdomen 
showing the tortuous trajectory and beaded appearance of the right and left renal arteries 
(Panel B and C, respectively). 
 
Figure 5. Left renal artery stenosis (arrow) demonstrated on a 3D reconstruction of the 
arterial phase of the CT-angiogram (Panel A). Pre- and post-stenting angiograms of the left 
renal artery (Panel B and C, respectively). 
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